Who is sponsoring NCT05198011?

NCT05198011 is sponsored by Hams Hamed Abdelrahman.

What drugs are being tested in NCT05198011?

Interventions in NCT05198011: 3D customized Titanium Mesh (Study), Conventional ridge augmentation (Control).

What condition does NCT05198011 study?

NCT05198011 studies Alveolar Bone Loss.

Is NCT05198011 still recruiting?

NCT05198011 is currently completed. Last updated 20 January 2022.

Last reviewed 2022-01-20 · How we verify

NCT05198011

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Three-Dimensional Printed Customized Titanium Mesh for Mandibular Augmentation

Completed NA Last updated 20 January 2022

What this trial tests

NA trial testing 3D customized Titanium Mesh (Study) in Alveolar Bone Loss in 14 participants. Completed in 30 April 2020.

Timeline

1 October 2019

Primary endpoint
30 April 2020

30 April 2020

Quick facts

Lead sponsor	Hams Hamed Abdelrahman
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	14
Start date	1 October 2019
Primary completion	30 April 2020
Estimated completion	30 April 2020
Sites	1 location across Egypt

Drugs / interventions tested

3D customized Titanium Mesh (Study)
Conventional ridge augmentation (Control)

Conditions studied

Alveolar Bone Loss — all drugs for Alveolar Bone Loss →

Sponsor

Hams Hamed Abdelrahman — full company profile →

Who can join

Adults 40 to 60, any sex, with Alveolar Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Completely or partially edentulous patients suffer from resorption of the alveolar bone, they always seek rehabilitation which becomes challenging. Alveolar ridge augmentation is widely done now to offer these patients functional and esthetic restoration. Many techniques have been proposed to obtain good results of ridge augmentation. Titanium Mesh (TiMe) is widely used, also digital and computer-guided surgery now plays an important role to improve the techniques and results in ridge augmentation procedures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Alveolar Bone Loss

Currently open trials in the same condition.

NCT07508033 — Evaluation of Stem Cell Exosomes Versus Platelet-Rich Fibrin in Tooth Extraction Socket Healing · Phase 1, PHASE2 · recruiting
NCT07375004 — Injectable PRF in Non-Surgical Periodontal Treatment · NA · active not recruiting
NCT07449806 — Assessment of Labial Plate Thickness After Immediate Implant Placement Using Two Different Xenografts in the Esthetic Zo · NA · recruiting
NCT07419269 — Comparison of Customized Allogenic Versus Autogenous Bone Block Graft for Alveolar Ridge Augmentation · NA · recruiting
NCT06887582 — Crestal Sinus Lifting in Periodontally-Compromised Patients Utilizing Autologous Dentin Graft · NA · active not recruiting

Other Hams Hamed Abdelrahman trials

Trials by the same sponsor.

NCT07044882 — Hydrodynamic Piezoelectric Technique in Internal Sinus Lift · NA · not yet recruiting
NCT07082634 — Immediate Implant Placement Using the Socket Shield Technique in Maxillary Esthetic Zone · NA · not yet recruiting
NCT07044895 — Diode Laser Photocoagulation With Immediate Implant Placement · NA · not yet recruiting
NCT06759311 — Two Different Minimal Invasive Techniques in Caries Removal of Primary Teeth · NA · active not recruiting
NCT07103564 — The Effect of Local Melatonin Application Around Immediately Placed Implants in the Maxillary Premolar · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05198011 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hams Hamed Abdelrahman
Last refreshed: 20 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05198011.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing